Focuses on developing innovative biofilm solutions to eliminate difficult fungal and bacterial infections, specifically targeting conditions like Recurrent Vulvovaginal Candidiasis with novel drug combinations. Aims to advance antimicrobial therapies and improve patient outcomes for chronic infections.